Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus.
about
Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndromeImpact of obesity on the risk for polycystic ovary syndromeDoes endothelial dysfunction correlate with endocrinal abnormalities in patients with polycystic ovary syndrome?Pancreatic β-cell dysfunction in polycystic ovary syndrome: role of hyperglycemia-induced nuclear factor-κB activation and systemic inflammation.Elevated androgens during puberty in female rhesus monkeys lead to increased neuronal drive to the reproductive axis: a possible component of polycystic ovary syndromeAssessment of insulin resistance and impaired glucose tolerance in lean women with polycystic ovary syndrome.Adverse effects of the common treatments for polycystic ovary syndrome: a systematic review and meta-analysis.Polycystic ovary syndrome and risk of endometrial, ovarian, and breast cancer: a systematic reviewInsulin resistance according to β-cell function in women with polycystic ovary syndrome and normal glucose tolerance.Regulation of adiponectin secretion by adipocytes in the polycystic ovary syndrome: role of tumor necrosis factor-{alpha}.Omega-3 supplementation effects on polycystic ovary syndrome symptoms and metabolic syndrome.Estradiol Binds to Insulin and Insulin Receptor Decreasing Insulin Binding in vitro.Association of Gly972Arg variant of insulin receptor subtrate-1 and Gly1057Asp variant of insulin receptor subtrate-2 with polycystic ovary syndrome in the Chinese population.Does polycystic ovary syndrome itself have additional effect on apelin levels?Insulin resistance and fertility in polycystic ovary syndromeThe expression of the miR-25/93/106b family of micro-RNAs in the adipose tissue of women with polycystic ovary syndromeAssociation study of polymorphism of FXIIIVal34Leu gene and polycystic ovary syndrome.Assessing and treating insulin resistance in women with polycystic ovarian syndromeEvaluation of early atherosclerotic findings in women with polycystic ovary syndrome.The Genetic Basis of the Polycystic Ovary Syndrome: A Literature Review Including Discussion of PPAR-gamma.Recent advances in the treatment of polycystic ovary syndrome.Abnormal expression of genes involved in inflammation, lipid metabolism, and Wnt signaling in the adipose tissue of polycystic ovary syndromeRelationship between Serum Lipoprotein Ratios and Insulin Resistance in Polycystic Ovary Syndrome.Progesterone levels on the hCG day and outcomes in vitro fertilization in women with polycystic ovary syndrome.Cardiometabolic aspects of the polycystic ovary syndrome.Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosisDo ACE I/D gene polymorphism serve as a predictive marker for age at onset in PCOS?Lack of Association of Vitamin D Receptor FokI (rs10735810) (C/T) and BsmI (rs1544410) (A/G) Genetic Variations with Polycystic Ovary Syndrome Risk: a Case-control Study from Iranian Azeri Turkish Women.Calpains and their multiple roles in diabetes mellitus.Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review.Indices of low-grade inflammation in polycystic ovary syndrome.Cardiovascular complications of obesity in adolescents.Is insulin resistance an intrinsic defect in asian polycystic ovary syndrome?Correlation of Serum Lipoprotein Ratios with Insulin Resistance in Infertile Women with Polycystic Ovarian Syndrome: A Case Control Study.Cardiometabolic health among gastric bypass surgery patients with polycystic ovarian syndrome.miRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance.Leptin levels in relation to marital status and neuroendocrine function in Iraqi females with polycystic ovary syndrome.Gender-specific care of diabetes mellitus: particular considerations in the management of diabetic women.Current trends in the treatment of polycystic ovary syndrome with desire for children.Triglycerides to High-Density Lipoprotein Cholesterol Ratio Can Predict Impaired Glucose Tolerance in Young Women with Polycystic Ovary Syndrome
P2860
Q24246323-5E2DA784-A6F7-4FEB-B7E4-16C1801A8EB7Q24680958-621786CD-060F-41E7-95E1-763B027FE6C2Q28079172-E30F993D-F233-48F0-9835-43BC9BC5C198Q30359255-C4393516-CA15-48F4-80B1-77A0EA8B1D1AQ30422591-0937C6EF-EAE6-4EA7-BCB1-33855E41DC67Q30429162-6C04B9A3-C298-453D-85A2-23F528DCBDB0Q33587839-8E130ED2-FF67-4A19-B822-A12117539F96Q33655236-05D61982-F4CC-4193-85C6-B57F16B03794Q33728447-ECC6479E-2606-4565-AB78-65F3CDF56F40Q33736175-5F9BAE44-494F-4AE5-BAD5-026BC27C0C30Q33771216-A25AB33C-44A0-404F-9450-1FBCE2A41608Q33923490-30A5C82D-FE66-4E7D-B41E-9418BFEB81DCQ34374698-2C85B7DA-FF59-4BCF-B654-E700AC75C52FQ34390789-DE05D31A-7CD4-4E42-9CE2-F6B99265F2FBQ34480793-D46F8A9F-80ED-4022-98A2-A8BCC5FB3C9DQ34628402-4DD998A1-CDFB-4FB8-9A14-5CC2FB186D31Q34770088-7238201F-88C3-4816-A1AA-FBCEB52EBC06Q34878055-85A78D4B-4D17-4028-9037-F25E4860912EQ35540579-F2EC13E4-55F7-454B-8D2A-62190447EE45Q35676497-8D8EA64E-1F87-4672-901D-9AD66A2B89C8Q35906966-F2122810-8D1A-4C0C-8178-E0C7BCF7B069Q35921384-58565A5A-415C-4D79-8AC8-CADE5FC58A27Q36076094-5AF56063-E199-410C-99FD-2E9A966A3AD6Q36106385-C7C3373A-C639-4B38-B0F7-6B7BD2EC4F75Q36287892-704D1DA2-6111-4A90-933F-3F5EF2D7A8EDQ36298211-5F0EB3AB-2257-43F9-96AA-E084BDFE490DQ36557299-CE61CF14-F7D0-4A86-AFFA-780F90A6788DQ36671284-002175B2-DEB4-4D6B-A44A-37DBC87CCB31Q36675894-BEDCE983-09A9-4084-9DE4-3928A3BA0066Q36721550-58B37B8B-68F4-4FE9-BAC8-87D6053E524BQ36739203-16D711D0-CF25-442B-A61A-F15CC2C3227AQ36743491-2BA14993-6EDA-44A2-9024-1688D6E67A38Q36793092-A72965E0-449B-476A-A147-EF3BEFB7FFA2Q36837104-D0F6423A-4A75-41F2-8314-3A34B458A9A5Q36923491-BA726E95-7966-44CB-AB08-336A5C847D25Q37015090-D1A41219-57CF-4CE4-B898-4165025E38B4Q37063275-480C7C5A-7D86-40D1-AD39-651C680C8741Q37169720-A0D55B55-574D-4D5A-8D41-BC97E93CF58FQ37230319-BFF94D3D-A443-40FA-B4CF-ADA8AA1FE294Q37231872-7D658EFE-332F-474C-845F-A12B2E79BC69
P2860
Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus.
@ast
Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus.
@en
Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus.
@nl
type
label
Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus.
@ast
Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus.
@en
Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus.
@nl
prefLabel
Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus.
@ast
Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus.
@en
Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus.
@nl
P921
P1476
Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus.
@en
P2093
Fernando Ovalle
P304
P356
10.1016/S0015-0282(02)03111-4
P407
P577
2002-06-01T00:00:00Z